膜式氧合系統市場規模、佔有率和成長分析：按材料類型、應用模式、患者組件尺寸、最終用戶和地區分類－2026-2033年產業預測

2024 年全球膜氧合市場價值為 14.5 億美元，預計到 2025 年將成長至 15.5 億美元，到 2033 年將成長至 26.4 億美元，在預測期（2026-2033 年）內複合年成長率為 6.9%。

全球膜式氧合器市場正經歷顯著成長，這主要得益於體外生命維持系統和心肺體外迴圈需求的不斷成長，而心血管手術和呼吸衰竭病例的增加又進一步推動了這一成長。技術進步正推動膜式氧合器從傳統的鼓泡式氧合器轉變為中空纖維膜轉變，後者俱有更高的氣體交換效率和生物相容性。肝素塗層膜和聚甲基戊烯等創新技術正在減少血栓症和溶血，延長患者的存活期。膜性能的提升增強了醫院擴大體外膜氧合（ECMO）應用的信心，鼓勵更長期的應用和對專案的投資。此外，監管核准的加強也促進了市場准入，使製造商能夠擴大生產規模並降低成本。人工智慧技術透過持續監測和數據驅動的調整進一步最佳化膜式氧合器的性能，加速了整合智慧體外生命支持系統的應用，並有助於改善臨床工作流程。

全球膜式氧合裝置市場按材質、應用、患者組件尺寸、最終用戶和地區進行細分。依材質分類，市場分為聚丙烯中空纖維、聚甲基戊烯（PMP）中空纖維、矽膠膜和其他材料。按應用分類，市場包括體外膜氧合（ECMO）、心肺體外迴圈（CPB）手術和其他應用。依患者組件尺寸分類，市場分為成人膜式氧合裝置及兒童及新生兒氧合裝置。依最終用戶分類，市場分為醫院和加護病房、專科心臟中心和門診手術中心。依地區分類，市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球膜氧合設備市場的成長要素

全球膜氧合市場正受到膜材料進步的顯著推動，這些進步顯著提升了膜材料的氣體滲透性、耐久性和生物相容性，使其達到遠超過以往預期的水平。這些進步使得臨床醫生能夠在更長時間或更複雜的手術中使用膜氧合技術。創新的聚合物選擇和各種表面處理技術降低了血栓形成和蛋白質積聚的可能性，從而降低了併發症風險並改善了患者預後。此外，製造技術的進步使得生產更薄、更堅固的膜成為可能，確保了膜的結構完整性，並促進了其在臨床環境中的廣泛應用。因此，這些材料的改進增強了醫療專業人員的信心，從而推動了對最新膜氧合系統的需求。

全球膜式氧合設備市場的限制因素

先進膜式氧合系統推廣應用的主要障礙在於其高昂的初始成本和生命週期成本，這對預算有限的醫療機構構成了挑戰。醫療機構往往會推遲採購，轉而選擇更便宜的替代方案或繼續使用過時的技術。此外，耗材的持續成本、灌注團隊的專業訓練需求以及設備的定期維護都會增加總擁有成本。因此，儘管這些創新系統性能優異，但小規模的醫療機構可能仍對其持謹慎態度。總體而言，買家對成本的敏感度日益增強，阻礙了市場擴張，尤其是在高階膜式氧合解決方案領域。

全球膜氧合市場趨勢

全球膜式氧合（MPO）市場正呈現與體外生命維持（ECLS）系統深度整合的顯著趨勢。製造商致力於開發採用標準化連接器和無縫監測介面的模組化設計，從而簡化先進治療環境中的臨床工作流程。這項轉變旨在最大限度地降低安裝複雜性，使醫療團隊能夠在緊急情況下更有效率地做出反應。此外，供應商與醫院採購團隊之間的合作正在推動滿足實際用戶需求的捆綁式解決方案的推出，從而提高了MPO在專科心臟護理和重症監護病房的普及率。這些旨在提升相容性和易用性的合作努力，標誌著MPO應用領域的一次變革性發展。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球膜式氧合器市場規模：依材料類型分類

• 聚丙烯中空纖維
• 聚甲基戊烯（PMP）中空纖維
• 矽膠膜
• 其他

全球膜式氧合器市場規模：按應用領域分類

• 體外膜氧合（ECMO）
  • 靜脈-動脈體外膜氧合（ECMO）
  • 靜脈-靜脈體外膜氧合（ECMO）
• 心肺體外迴圈（CPB）手術
• 其他

全球膜式氧合系統市場規模：依病患組件尺寸分類

• 成人膜式氧合裝置
• 兒童及新生兒氧合裝置

全球膜氧合系統市場規模：依最終用戶分類

• 醫院及加護病房
• 專業心臟病中心
• 門診手術中心

全球膜氧合系統市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Medtronic
• Fresenius SE
• Getinge
• Terumo Corporation
• MicroPort Scientific
• Nipro Corporation
• Kewei Medical
• Braile Biomedica
• LivaNova
• Chalice Medical
• Abbott Laboratories
• AbbVie
• Inspira Technologies
• Sorin
• Maquet
• Spectrum Medical
• Xenios AG
• Eurosets
• Medos Medizintechnik
• Novalung

結論與建議

Global Membrane Oxygenators Market size was valued at USD 1.45 Billion in 2024 and is poised to grow from USD 1.55 Billion in 2025 to USD 2.64 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global membrane oxygenators market is experiencing significant growth driven by the increasing need for extracorporeal life support and cardiopulmonary bypass due to the rise in cardiac procedures and respiratory failures. Advancements have shifted the technology from traditional bubble oxygenators to more effective hollow fiber membranes, enhancing gas exchange and biocompatibility. Innovations like heparin-coated membranes and polymethylpentene designs reduce thrombosis and hemolysis, enabling prolonged patient survival. Improved membrane performance fosters hospital confidence in expanding ECMO usage, supporting longer applications and investments in dedicated programs. Additionally, enhanced regulatory clearances facilitate market access, allowing manufacturers to scale production and lower costs. AI technologies are further optimizing membrane oxygenator performance through continuous monitoring and data-driven adjustments, promoting integrated intelligent ECLS systems and improving clinical workflows.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Membrane Oxygenators market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Membrane Oxygenators Market Segments Analysis

The global membrane oxygenators market is segmented by material type, application form, patient component size, end-user, and region. Based on material type, the market is segmented into Polypropylene Hollow Fiber, Polymethylpentene (PMP) Hollow Fiber, Silicone Membrane, and Others. Based on the application form, the market is segmented into Extracorporeal Membrane Oxygenation (ECMO), Cardiopulmonary Bypass (CPB) Surgery, and Others. Based on patient component size, the market is segmented into Adult Membrane Oxygenators and Pediatric and Neonatal Oxygenators. Based on end-user, the market is segmented into Hospitals and Intensive Care Units, Specialized Cardiac Centers, and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Driver of the Global Membrane Oxygenators Market

The global Membrane Oxygenators market is being significantly driven by advancements in membrane materials that enhance gas transfer efficiency, durability, and biocompatibility beyond previous expectations. These improvements enable clinicians to utilize membrane oxygenators for extended and more intricate procedures. Innovative polymer selections and various surface treatments reduce thrombogenic potential and protein accumulation, leading to lower complication risks and improved patient outcomes. Additionally, advancements in manufacturing techniques have allowed for the production of thinner yet robust membranes, ensuring structural integrity and facilitating wider acceptance in clinical settings. Consequently, these material enhancements are fostering increased confidence among healthcare providers, thereby fueling the demand for modern membrane oxygenator systems.

Restraints in the Global Membrane Oxygenators Market

The adoption of advanced membrane oxygenators faces significant restraints primarily due to their elevated acquisition and lifecycle costs, which pose challenges for healthcare systems with constrained budgets. Institutions often delay purchases, opting for less expensive alternatives or continuing to utilize outdated technologies. Furthermore, ongoing expenses related to disposables, the need for specialized training for perfusion teams, and routine device maintenance contribute to an increased total cost of ownership. Consequently, smaller healthcare facilities may be reluctant to embrace innovative systems despite their promising performance. Overall, heightened cost sensitivity among purchasers hampers market expansion, particularly for high-end membrane oxygenator solutions.

Market Trends of the Global Membrane Oxygenators Market

The Global Membrane Oxygenators market is experiencing a notable trend towards enhanced integration within extracorporeal life support systems. Manufacturers are focusing on developing modular designs with standardized connectors and seamless monitoring interfaces, thereby streamlining clinical workflows in high-acuity environments. This shift aims to minimize setup complexity, allowing healthcare teams to respond more efficiently during critical situations. Additionally, partnerships between suppliers and hospital procurement teams are fostering bundled offerings that cater to real-world user needs, promoting stronger adoption rates in specialized cardiac and critical care units. This concerted effort to enhance compatibility and usability signifies a transformative evolution in the use of membrane oxygenators.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Membrane Oxygenators Market Size by Material Type & CAGR (2026-2033)

• Market Overview
• Polypropylene Hollow Fiber
• Polymethylpentene (PMP) Hollow Fiber
• Silicone Membrane
• Others

Global Membrane Oxygenators Market Size by Application Form & CAGR (2026-2033)

• Market Overview
• Extracorporeal Membrane Oxygenation (ECMO)
  • Veno-Arterial ECMO
  • Veno-Venous ECMO
• Cardiopulmonary Bypass (CPB) Surgery
• Others

Global Membrane Oxygenators Market Size by Patient Component Size & CAGR (2026-2033)

• Market Overview
• Adult Membrane Oxygenators
• Pediatric and Neonatal Oxygenators

Global Membrane Oxygenators Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals and Intensive Care Units
• Specialized Cardiac Centers
• Ambulatory Surgical Centers

Global Membrane Oxygenators Market Size & CAGR (2026-2033)

• North America (Material Type, Application Form, Patient Component Size, End-User)
  • US
  • Canada
• Europe (Material Type, Application Form, Patient Component Size, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Material Type, Application Form, Patient Component Size, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Material Type, Application Form, Patient Component Size, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material Type, Application Form, Patient Component Size, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kewei Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chalice Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inspira Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sorin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Maquet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spectrum Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xenios AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurosets
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medos Medizintechnik
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novalung
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations